News
ATRC
61.42
-0.15%
-0.09
Weekly Report: what happened at ATRC last week (1019-1023)?
Weekly Report · 2d ago
AtriCure to Participate at Upcoming Investor Conferences
Barchart · 2d ago
AtriCure Is Maintained at Market Outperform by Citizens
Dow Jones · 10/21 13:16
Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68
Benzinga · 10/21 13:06
AtriCure price target raised to $68 from $52 at Citizens
TipRanks · 10/21 09:50
Weekly Report: what happened at ATRC last week (1012-1016)?
Weekly Report · 10/19 09:47
Press Release: AtriCure to Announce Third Quarter 2026 Financial Results
Dow Jones · 10/13 12:21
BTIG Maintains Buy on AtriCure, Raises Price Target to $63
Benzinga · 10/12 09:54
Weekly Report: what happened at ATRC last week (1005-1009)?
Weekly Report · 10/12 09:50
Weekly Report: what happened at ATRC last week (0928-1002)?
Weekly Report · 10/05 09:50
Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 10/02 12:58
This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Benzinga · 10/02 12:42
AtriCure Cut to Hold From Buy by Freedom Capital Markets
Dow Jones · 10/02 12:01
AtriCure Price Target Raised to $57.00/Share From $43.00 by Freedom Capital Markets
Dow Jones · 10/02 12:01
Freedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57
Benzinga · 10/02 11:52
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)
TipRanks · 10/02 10:30
AtriCure downgraded to Hold from Buy at Freedom Capital
TipRanks · 10/02 10:20
Weekly Report: what happened at ATRC last week (0921-0925)?
Weekly Report · 09/28 09:47
Biotech Stocks At 52-Week Highs - TKNO, MRNA, ATRC, ILMN
NASDAQ · 09/24 09:26
Weekly Report: what happened at ATRC last week (0914-0918)?
Weekly Report · 09/21 09:47
More
Webull provides a variety of real-time ATRC stock news. You can receive the latest news about Atricure through multiple platforms. This information may help you make smarter investment decisions.
About ATRC
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.